Remarkably, in BALF of a small cohort of patients with IAV-induced ARDS, PLET1 concentrations negatively correlated with a marker of alveolar injury, underscoring Plet1 administration as a putative therapeutic approach in patients with virus-induced lung injury and beyond, that are urgently needed to date. This evidence concerns the gene PLET1 and acute respiratory distress syndrome.